Notes to the consolidated financial statements 17 Investments in associates and joint ventures Total Associates m At 1 April 2005 3 Exchange differences 1 At 31 March 2006 4 Additions 3 At 31 March 2007 7 Additions comprise Microbia Precision Engineering Inc, Lumora Limited and Eridania Sadam note 41.
Details of the impact of Associates on the Group income statement and balance sheet are summarised below: Income statement Year to 31 March 2007 2006 m m Sales 4 3 Expenses 4 3 Profit before tax Income tax expense Profit for the year Balance sheet 31 March 2007 2006 m m Assets 14 7 Liabilities 7 3 Net assets 7 4 Joint ventures The Groups joint ventures, which are proportionately consolidated, are listed in note 41.
The amounts proportionately consolidated in the Group income statement and balance sheet are summarised below: Income statement Year to 31 March 2007 Year to 31 March 2006 Continuing Discontinued Continuing Discontinued operations operations operations operations m m m m Sales 322 67 294 78 Expenses 279 34 258 68 Profit before tax 43 33 36 10 Income tax expense 11 6 8 1 Profit for the year 32 27 28 9 Balance sheet 31 March 2007 2006 m m Assets Non-current assets 221 190 Cash and cash equivalents 45 30 Other current assets 183 134 449 354 Liabilities Non-current borrowings 4 1 Other non-current liabilities 45 16 Current borrowings 25 27 Other current liabilities 61 43 135 87 Net assets 314 267 The Groups proportionate interest in joint ventures commitments and contingent liabilities was 11 million.
Tate & Lyle Annual Report 2007 109 STATUTORY INFORMATION HOW WE RUN THE BUSINESS HOW WE PERFORMED WHAT WE DO OVERVIEW OF THE YEAR
